Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 1:00 PM ET


Company Overview of Aspireo Pharmaceuticals Ltd.

Company Overview

Aspireo Pharmaceuticals Ltd. develops compounds for the treatment of acromegaly and certain hormone active tumor types resulting from hypophyse disorders. It offers Somatoprim (DG3173), a novel somatostatin analogue that regulates endocrine system and affects neurotransmission and cell proliferation via interaction with G-protein-coupled somatostatin receptors and inhibition of the release of various secondary hormones. The company provides Somatoprim to treat patients with the various indications, including acromegaly, carcinoid tumors, GEP-NET, diabetic retinopathy, and cushings diseases. Aspireo Pharmaceuticals Ltd. is based in Tel Aviv, Israel.

Tel Aviv,  


Key Executives for Aspireo Pharmaceuticals Ltd.

Chief Executive Officer
Chief Financial Officer
Age: 65
Chief Business Officer
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Fertility Labs Ltd. Middle East/Africa
Chi2gel Ltd. Middle East/Africa
GNE Global Natural Energy Ltd. Middle East/Africa
Slo-Flo Ltd. Middle East/Africa
ITOS Middle East/Africa

Recent Private Companies Transactions

May 15, 2015
Aspireo Pharmaceuticals Ltd, Somatoprim (DG3173)

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aspireo Pharmaceuticals Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at